What Medicare Pays for Blood Tests in 2027 Hinges on Lab Data Due by July 31

Applicable clinical laboratories have until July 31, 2026, to submit private payer rate data to CMS through the agency's data portal, or risk civil monetary penalties. The reporting window opened May 1. Labs are required to provide data on what private insurers actually paid them from January through June 2025. CMS uses those figures to set the Clinical Laboratory Fee Schedule rates that take effect January 1, 2027. Those rates determine how much Medicare pays when a doctor orders a blood count, urinalysis, metabolic panel, biopsy, or other lab service for a beneficiary in traditional Medicare or Medicare Advantage. The law governing this process, the Protecting Access to Medicare Act, requires labs to periodically report their real-world private payer prices so that Medicare's payment rates stay closer to market levels rather than older benchmarks. Laboratories covered by the requirement include most independent labs, physician office labs, and hospital outreach labs that bill Medicare Part B. CMS reminded providers of the July 31 deadline in its July 23 Medicare Learning Network newsletter. The reporting cycle matters for beneficiaries because the resulting fee schedule affects both what Medicare pays and the cost sharing that enrollees owe when they receive lab services. When labs do not report or report late, the data CMS uses to set rates can become less accurate, with ripple effects on Medicare's reimbursement calculations.